Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome

Journal of Rheumatology

Volumn 34, Issue 11, 2007, Pages 2253-2258

  Salliot, Carine ^a   Gottenberg, Jacques Eric ^a   Bengoufa, Djaouida ^b   Desmoulins, Frédéric ^a   Miceli Richard, Corinne ^a   Mariette, Xavier ^a  

^a BICÊTRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Anticentromere antibodies; Autoimmune overlap syndrome; Sj gren's syndrome

Indexed keywords

CENTROMERE ANTIBODY; CENTROMERE PROTEIN B; LA ANTIBODY; RO ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; XEROPHTHALMIA;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CENTROMERE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SJOGREN'S SYNDROME; SYNDROME;

EID: 35948952842     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Skopouli FN, Moutsopoulos HM. Autoimmune epitheliitis: Sjogren's syndrome. Clin Exp Rheumatol 1994;12 Suppl 11:S9-11.
2. Fox RI. Sjogren's syndrome. Lancet 2005;366:321-31.
3. Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979;66:733-6.
4. Coll J, Rives A, Grino MC, Setoain J, Vivancos J, Balcells A. Prevalence of Sjogren's syndrome in autoimmune diseases. Ann Rheum Dis 1987;46:286-9.
5. Salliot C, Mouthon L, Ardizzone M, et al. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology Oxford 2007;46:321-6.
6. Fritzler MJ, Kinsella TD, Garbutt E. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980;69:520-6.
7. Spencer-Green G, Alter D, Welch HG. Test performance in systemic scleroderma: anticentromere and anti-Scl-70 antibodies. Am J Med 1997;103:242-8.
8. Reveille JD, Solomon DH, the ACR Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70 and nucleolar antibodies. Arthritis Care Res 2003;49:399-412.
9. Chan HL, Lee YS, Hong HS, Kuo TT. Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol 1994;19:298-302.
10. Pope JE. Scleroderma overlap syndromes. Opin Rheumatol 2002;14:704-10.
11. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005;32:1488-94.
12. Von Mulhen CA, Tan EM. Antibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58.
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
14. Masi AT, Rodnan JP, Medsger TA Jr, et al. Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581.
15. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
16. Chisholm D, Mason D. Labial salivary gland biopsy in Sjogren's syndrome. J Clin Pathol 1968;21:656-60.
17. Preud'homme JL, Danon F, Rochard E, et al. Detection of anti-double stranded DNA antibodies of IgG, IgA and IgM classes by ELISA. Comparison with the Farr test and indirect immunofluorescence. Presse Med 1988;17:1401-4.
18. Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med 1971;50:302-12.
19. Renier G, Le Normand I, Chevailler A, Verret JL, Renier JC, Huriez D. Anticentromere antibodies. Study of 67 positive sera. Rev Med Int 1992;13:413-8.
20. Tubach F, Hayem G, Elias A, et al. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rheum Engl Ed 1997;64:362-7.
21. Katano K, Mitsuhiro K, Ichiro K, Susumu S, Yoshinao M. Clinical and laboratory features of anticentromere antibody-positive primary Sjogren's syndrome. J Rheumatol 2001;28:2238-44.
22. Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC. Centromere protein C is a target of autoantibodies in Sjogren's syndrome and is uniformly associated with antibodies to Ra and La. J Rheumatol 2004;31:1121-5.
23. Ramos-Casals M, Nardi N, Brito-Zeron P, et al. Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006;35:312-21.
24. Gelber AC, Pillemer SR, Baum BJ, et al. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma. Ann Rheum Dis 2006;65:1028-32. Epub 2006 Jan 13.
25. Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993;32:297-301.
26. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM. Microvascular abnormalities in Sjogren's syndrome: nailfold capillaroscopy. Rheumatology Oxford 1999;38:826-30.
27. Caramaschi P, Biasi D, Carletto A, et al. Sjogren's syndrome with anticentromere antibodies. Rev Rheum Engl Ed 1997;64:785-8.
28. Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjogren's syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum 2007;36:246-55. Epub 2006 Sep 22.
29. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupuserythematosus. N Engl J Med 2003;349:1526-33.
30. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
31. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003;48:2240-5.
32. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986;232:1145-7.
33. Gottenberg JE, Busson M, Loiseau P, et al. Association of transforming growth factor beta 1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum 2004;50:570-80.
34. Sato H, Lagan AL, Alexopoulou C, et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis Rheum 2004;50:558-64.
35. Reveille JD. The molecular genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 1992;4:644-56.
36. Gilchrist FC, Bunn C, Foley PJ, et al. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun 2001;2:76-81.